Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Policy Forum Dec 2004 Cost and Clinical Practice Guidelines: Can Two Wrongs Make It Right? Ellen K. Hummel, MD and Peter A. Ubel, MD In today's medical economy, cost effectiveness is becoming a bigger factor in developing standardized clinical practice guidelines. Virtual Mentor. 2004;6(12):558-560. doi: 10.1001/virtualmentor.2004.6.12.pfor1-0412. Pagination First page « First Previous page ‹ Previous … Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Current page 30
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Policy Forum Dec 2004 Cost and Clinical Practice Guidelines: Can Two Wrongs Make It Right? Ellen K. Hummel, MD and Peter A. Ubel, MD In today's medical economy, cost effectiveness is becoming a bigger factor in developing standardized clinical practice guidelines. Virtual Mentor. 2004;6(12):558-560. doi: 10.1001/virtualmentor.2004.6.12.pfor1-0412.